Summary: Creative Biolabs has established the Hi-AffiTM platform to develop high affinity human monoclonal antibodies derived from non-human primates (NHPs). This platform, known as the Hi-Affi™ human antibody platform, can offer higher affinity antibodies than humanized antibodies originated from other species, such as widely used murine antibodies. https://www.creative-biolabs.com/High-Affi-TM-Human-Antibody-Discovery.html
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
